Raju Prasad
Patrimonio netto: 710 972 $ in data 31/07/2026
Patrimonio netto: 710 972 $ in data 31/07/2026
Raju Prasad is currently Chief Financial & Accounting Officer at CRISPR Therapeutics AG since 2023.
Formerly, Dr. Prasad was a Research Analyst at William Blair & Co. LLC from 2014 to 2023 and a Research Associate at the University of North Carolina at Chapel Hill.
Education includes an undergraduate degree from Rutgers State University of New Jersey, a graduate degree from the University of Delaware, and a doctorate from The University of North Carolina at Charlotte.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 07/08/2026 | 14.815 ( 0,02% ) | 710 972 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CRISPR THERAPEUTICS AG | Direttore Finanziario/CFO | 14/03/2023 |
| Società | Posizione | Fine |
|---|---|---|
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/03/2023 |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale